Pages that link to "Q36618871"

The following pages link to Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer (Q36618871):

Displaying 17 items.

• Triple-negative breast cancer: is there a treatment on the horizon? (Q28077243) (← links)
• Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer (Q37182974) (← links)
• Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study. (Q37385672) (← links)
• Clinical response in patients with ovarian cancer treated with metronomic chemotherapy (Q37679904) (← links)
• Metformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models (Q37709392) (← links)
• Targeting Hypoxia-Inducible Factors for Antiangiogenic Cancer Therapy (Q38674277) (← links)
• Metronomic chemotherapy for triple negative breast cancer? (Q42523304) (← links)
• Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now? (Q47732726) (← links)
• The role of tumor microenvironment in resistance to anti-angiogenic therapy. (Q52645823) (← links)
• Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. (Q55292678) (← links)
• Nonhormonal selective estrogen receptor modulator 1-(2-[4-{(3R,4S)-7-Methoxy-2, 2-dimethyl-3-phenyl-chroman-4yl}phenoxy]ethyl)pyrrolidine hydrochloride (ormeloxifene hydrochloride) for the treatment of breast cancer (Q57026362) (← links)
• High-resolution deconstruction of evolution induced by chemotherapy treatments in breast cancer xenografts (Q60301437) (← links)
• Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience (Q64071354) (← links)
• A Pilot Study of Extended Adjuvant Therapy with Metronomic Docetaxel for Patients with Operable Triple-Negative Breast Cancer (Q90654910) (← links)
• Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy (Q91256518) (← links)
• Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells (Q91675444) (← links)
• Vessel co-option in cancer (Q91997710) (← links)